30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now

Peter Barrett

Track

Insider profile

Currently holds positions in Larimar Therapeutics Inc, Synlogic Inc, Vitae Pharmaceuticals LLC and Revvity Inc

Performance

Overall performance
2.2
Performance over holding periods
2.2
30 days 90 days 120 days
Average return 2% 8.2% 15.1%
Success rate 59% 68% 82%
Transactions
2 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance

Positions

Position Company Period
Independent Chairman of the Board Larimar Therapeutics Inc Jan. 1, 2014 -
Independent Chairman of the Board Synlogic Inc Aug. 28, 2017 -
Independent Director Vitae Pharmaceuticals LLC Dec. 1, 2004 -
Independent Director Revvity Inc Feb. 7, 2012 -
Chairman of the Board Larimar Therapeutics Inc Aug. 1, 2006 - Jan. 1, 2014
Independent Director SciClone Pharmaceuticals Inc April 18, 2011 - June 27, 2013
Peter Barrett's trades of Larimar Therapeutics Inc's stock


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2023-07-24 2023-07-24
PrS Proposed sale
16,469
483.82
US$3,848,414 		16,469 483.82 US$3,848,414
2020-05-29 2020-05-28
US Revvity Inc (RVTY)
S Sale
7,784 -8.8%
463.01
US$552,010 		7,784 -8.8% 463.01 US$552,010
2019-02-14 2019-02-13
US Revvity Inc (RVTY)
S Sale
3,128 -46.9%
308.00
US$2,626,538 		3,128 -46.9% 308.00 US$2,626,538